drugset / Trial / NCT06172361

Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica

NCT06172361

Phase 3 Recruiting 98 enrolled Zhejiang University
RandomizedParallel-groupOpen-labelTreatment

Summary

This will be efficacy and safety of Induction and Tapering Therapy with Tofacitinib and Glucocorticoid in patients with Polymyalgia Rheumatica (ITTG PMR): An open-label 52-week randomized controlled trial

Timeline

Start
2024-01-20
Primary completion
2025-09-30
Completion
2026-01-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Prednisone Other / unclassified 5 mg
Comparator Prednisone Other / unclassified 10 mg
Subject Tofacitinib Small molecule 5 mg